Dr. Gregory M. Vercellotti, MD

Dr. Vercellotti practices at M Health Fairview University of Minnesota Medical Center in Minneapolis, Minnesota, part of M Health Fairview.

Dr. Vercellotti's NPI, 1912008921, was assigned on September 25, 2006. Dr. Vercellotti graduated from University of Illinois College of Medicine - Chicago in 1976. Dr. Vercellotti holds Minnesota license 25121.

Dr. Vercellotti's primary practice is M Health Fairview University of Minnesota Medical Center, at 2450 Riverside Avenue, Minneapolis, MN 55454 in Hennepin County. The practice phone is (612) 624-1765.

Dr. Vercellotti's primary practice is M Health Fairview University of Minnesota Medical Center in Minneapolis, Minnesota, part of M Health Fairview. Dr. Vercellotti is also affiliated with M Health Fairview Southdale Hospital. The medical group on file is M Health Fairview Recovery Clinic. Dmand AI also links Dr. Vercellotti to 3 more hospitals, 8 medical groups, 7 group practices and clinics and 1 dialysis center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Vercellotti practices, 13 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Vercellotti's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Vercellotti is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Vercellotti's licenses on file in 2 states: Minnesota and Wisconsin.

Dmand AI lists chronic anemia, chronic leukemia, immune deficiency disease, multiple myeloma and purpura and thrombocytopenia among the conditions Dr. Vercellotti treats.

CMS data shows 278 Medicare services from Dr. Vercellotti across 7 procedure codes in 2024, for 118 Medicare patients. Medicare paid $17,351 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 118 Medicare patients who saw Dr. Vercellotti in 2024. The largest group is 65 to 74, with 44 patients. 75% of them have high blood pressure, and 64% have high cholesterol. 30% are also on Medicaid. Their average risk score is 3.52, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Vercellotti's median patient age at 66, with 57% women.

In 2024, Dr. Vercellotti wrote 686 Medicare Part D claims for 73 patients. 81% of them were for generic drugs. CMS names the drug for 397 of them, across 19 drugs with 11 or more claims each, at $359,535 in total drug cost. In 2023, CMS named 279 claims across 14 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Vercellotti for performance year 2024, reported as part of a group. Dr. Vercellotti accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Vercellotti as offering telehealth.

Dmand AI links 224 papers to Dr. Vercellotti, published from 2003 to 2025. 2018 was the busiest year, with 10. The most frequent topics are Anemia, Sickle Cell, Endothelium, Vascular and Cells, Cultured. Dr. Vercellotti has published most often in Blood. Dr. Vercellotti's most frequent co-authors are Karl A. Nath, MD, Veronika Bachanova, MD and Bruce Robert Blazar, MD.

Dmand AI links Dr. Vercellotti to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Purpura, Thrombotic Thrombocytopenic and Thrombophilia.

CMS Open Payments shows 20 general payments to Dr. Vercellotti from 12 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 79% of the total. Sanofi and Genzyme US Companies paid the most, $10,297. It also lists 1 research payment totaling $1,200 in 2023.

Dmand AI lists 4 awards for Dr. Vercellotti, most recently Regional Top Doctor in 2014.

Dr. Vercellotti graduated from University of Illinois College of Medicine - Chicago in 1976.

Dr. Vercellotti is in network with 14 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.